FRANKFURT, Germany and HANGZHOU, China, June 24, 2026 /PRNewswire/ -- Valgen Medtech recently announced that its proprietary DragonFly™ Transcatheter Mitral Valve Repair System has received CE mark approval in the European Union for the treatment of Functional Mitral
Home
Immediapress
Pr Newswire
Comunicato stampa - contenuto promozionale
Responsabilità editoriale PrNewswire
PorTal Access Announces FDA Clearance of FLEXI-PORT™ family of implantable vascular access ports
CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study
BrightHeart Announces CE Mark and European Launch of its AI Platform for Prenatal Ultrasound
The PREVAILS study, now fully enrolled, marks a critical step toward simultaneous regulatory submissions in China and Europe for…
WILMINGTON, Del., July 6, 2026 /PRNewswire/ -- Reprotech today announced that the TMRW Vault® has received CE marking as a Class…
HONG KONG, May 25, 2026 /PRNewswire/ -- Cornerstone Robotics ('CSR'), a leading global innovator in surgical robotics based in…
SpinaFX Medical Receives CE Mark MDR Certification for its Triojection® System, Expanding Access to Minimally Invasive Lumbar…
United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion
United Therapeutics received FDA approval for LungFX, a device designed to expand donor lung use in transplantation.
